News
Exopharm (ASX: EX1) has changed its name to Tryptamine Therapeutics - TYP (ASX: TYP).
Below are the previous articles from Exopharm (ASX: EX1):
RELATED STOCKHEAD STORIES
Experts
Value in new medicines and ‘longer strides’
News
Last Orders: What you might have missed on the ASX today
Experts
MoneyTalks: A few more hot picks out of COVID from Canary Capital
Health & Biotech
Exopharm’s LEAP technology a breakthrough in exosome therapeutics
Health & Biotech
Exopharm has just dosed it first patient in a wound-healing study
Health & Biotech
Health Kick Podcast: This biopharma company may be the world’s only exosome-based player
Health & Biotech
How mRNA vaccines could defeat the novel coronavirus
Health & Biotech
Check up: Health sector slips as earning season ends
News
ASX Small Cap Lunch Wrap: ‘Only in America’ edition
Health & Biotech
Canary Capital sees explosive potential in Exopharm
Health & Biotech
Nanoveu says there are other ways to clean your phone from corona, shares fly
Health & Biotech
Are we mortgaging the future as COVID-19 closes clinical trials?
Health & Biotech
Biotech: It’s not a get-rich-quick scheme judging by these HY reports
Health & Biotech
Biotech: Exopharm arouses market over potential to treat erectile dysfunction
News
Health: Is this company onto an alternative to stem cell therapy?
Health & Biotech
Health: New US guidelines on breast cancer may help this ASX biotech
Health & Biotech
